3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.43%
Revenue growth above 1.5x M7U.DE's 5.11%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
8.32%
Gross profit growth at 50-75% of M7U.DE's 14.19%. Martin Whitman would question if cost structure or brand is lagging.
229.06%
EBIT growth above 1.5x M7U.DE's 139.46%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
229.06%
Operating income growth above 1.5x M7U.DE's 120.05%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
133.80%
Net income growth at 75-90% of M7U.DE's 171.04%. Bill Ackman would press for improvements to catch or surpass competitor performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
26.96%
10Y revenue/share CAGR under 50% of M7U.DE's 62.69%. Michael Burry would suspect a lasting competitive disadvantage.
26.96%
5Y revenue/share CAGR under 50% of M7U.DE's 158.29%. Michael Burry would suspect a significant competitive gap or product weakness.
26.96%
3Y revenue/share CAGR similar to M7U.DE's 26.19%. Walter Schloss would assume both companies experience comparable short-term cycles.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
63.31%
Below 50% of M7U.DE's 154.44%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
63.31%
5Y net income/share CAGR above 1.5x M7U.DE's 26.09%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
63.31%
Below 50% of M7U.DE's 155.00%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
18.10%
Equity/share CAGR of 18.10% while M7U.DE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
18.10%
Equity/share CAGR of 18.10% while M7U.DE is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
18.10%
Positive short-term equity growth while M7U.DE is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.59%
AR growth of 21.59% while M7U.DE is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
3.91%
We show growth while M7U.DE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
0.82%
Positive asset growth while M7U.DE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
No Data
No Data available this quarter, please select a different quarter.
-16.86%
We’re deleveraging while M7U.DE stands at 22.99%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-2.97%
We cut SG&A while M7U.DE invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.